Clinical Trials Logo

Panic Disorder clinical trials

View clinical trials related to Panic Disorder.

Filter by:

NCT ID: NCT00535964 Completed - Panic Disorder Clinical Trials

Evaluating the Relationship Between Tobacco Use, Anxiety Sensitivity, and Panic in Adolescents

Start date: June 2007
Phase:
Study type: Observational

This study will determine whether there is a relationship between tobacco use and a heightened response to panic-producing events among adolescents. This study is fundamental research. It was not a Clinical Trial.

NCT ID: NCT00525226 Completed - Depression Clinical Trials

Evaluating the Effects of Stress in Pregnancy

Start date: September 2007
Phase: N/A
Study type: Observational

This study will evaluate pregnant women with a past or current diagnosis of depression or anxiety to gain a better understanding of how these disorders can affect an infant's development, both during and after pregnancy.

NCT ID: NCT00521352 Completed - Clinical trials for Major Depressive Disorder

Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression

rTMS
Start date: October 2007
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy of 1-Hz rTMS applied to the right Dorsolateral Prefrontal Cortex (DLPFC) in patients with Panic Disorder (PD) and comorbid Major Depressive Disorder (MDD) who have not fully responded to conventional therapies. The investigators hypothesize that: 1. compared to sham (placebo), active rTMS will improve symptoms of PD and MDD as assessed with the Panic Disorder Severity Scale (PDSS), Hamilton Depression Rating Scale (HDRS), and Clinical Global Impression (CGI); 2. active (but not sham) rTMS will normalize levels of motor cortex excitability relative to pre-treatment baseline.

NCT ID: NCT00515996 Recruiting - Panic Disorder Clinical Trials

Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy

Start date: January 2006
Phase: N/A
Study type: Observational

We plan to examine genetic polymorphism of catechol-O-methyltransferase in panic disorder and neurobiological changes of panic disorder patients after 12 weeks of pharmacotherapy with paroxetine. We plan to include 40 panic disorder patients and 40 normal control subjects in this study for 3 years.

NCT ID: NCT00492414 Recruiting - Panic Disorder Clinical Trials

Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release

Start date: n/a
Phase: Phase 4
Study type: Interventional

Panic disorder(PD)is a disabling psychiatric condition associated with significant impairment in psychosocial, occupational functioning and quality of life, as mentioned by mogotsi et al. So, most patients with panic disorder suffers from the consequences of the impairment in occupational function. This impairment is not only individual problem, but also social one. Since productivity is very important item required to employees, lost productive time among workers with psychiatric illness should be reduced by the proper management. But few data were reported in this field by now.

NCT ID: NCT00477451 Completed - Clinical trials for Treatment of Induced Panic Attack

Staccato Alprazolam in Panic Attack

Start date: May 2007
Phase: Phase 2
Study type: Interventional

We are developing Staccatoâ„¢ Alprazolam for the treatment of Panic attacks associated with panic disorder. This study will provide an initial assessment of efficacy, and to continue to describe the tolerability and pharmacokinetics, of a single inhaled dose of Staccato Alprazolam on a doxapram-induced panic attack in patients with panic disorder.

NCT ID: NCT00457106 Completed - Panic Disorder Clinical Trials

A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks

Start date: June 2002
Phase: N/A
Study type: Interventional

This study compares the efficacy of risperidone to that of paroxetine in the treatment of panic attacks in patients with Panic Disorder and with Major Depressive Disorder with Panic attacks and compares the side effect profile of risperidone vs. paroxetine in treatment of panic attacks and compares response rates of risperidone vs. paroxetine in treatment of panic attacks.

NCT ID: NCT00456768 Completed - Panic Disorder Clinical Trials

Efficacy of Treatment for Panic Disorder

Start date: May 2003
Phase: N/A
Study type: Observational

The purpose of these questionnaires is to give us an overview of how panic has affected your life and perhaps also to give us some clues about things that may have set you up to experience panic.

NCT ID: NCT00438971 Completed - Panic Disorder Clinical Trials

The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder

Start date: August 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether duloxetine is effective in the treatment of panic disorder.

NCT ID: NCT00438386 Completed - Clinical trials for Generalized Anxiety Disorder

Aripiprazole for the Treatment of Refractory Anxiety

Start date: April 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether aripiprazole is effective in the treatment of refractory panic and generalized anxiety disorder.